203 related articles for article (PubMed ID: 28119415)
21. ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells.
Plotnik JP; Budka JA; Ferris MW; Hollenhorst PC
Nucleic Acids Res; 2014 Oct; 42(19):11928-40. PubMed ID: 25294825
[TBL] [Abstract][Full Text] [Related]
22. Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation.
Carrero ZI; Kollareddy M; Chauhan KM; Ramakrishnan G; Martinez LA
Oncotarget; 2016 Mar; 7(11):12554-67. PubMed ID: 26871468
[TBL] [Abstract][Full Text] [Related]
23. ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63.
Torres A; Alshalalfa M; Davicioni E; Gupta A; Yegnasubramanian S; Wheelan SJ; Epstein JI; De Marzo AM; Lotan TL
Prostate; 2018 Sep; 78(12):896-904. PubMed ID: 29761525
[TBL] [Abstract][Full Text] [Related]
24. Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition.
Chang H; Liu Y; Xue M; Liu H; Du S; Zhang L; Wang P
Nucleic Acids Res; 2016 Apr; 44(6):2514-27. PubMed ID: 26926107
[TBL] [Abstract][Full Text] [Related]
25. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence.
Ohtani N; Zebedee Z; Huot TJ; Stinson JA; Sugimoto M; Ohashi Y; Sharrocks AD; Peters G; Hara E
Nature; 2001 Feb; 409(6823):1067-70. PubMed ID: 11234019
[TBL] [Abstract][Full Text] [Related]
26. E26 Transformation-Specific Transcription Factor ETS2 as an Oncogene Promotes the Progression of Hypopharyngeal Cancer.
Liu X; Zhang C; Zhang Z; Zhang Z; Ji W; Cao S; Cai X; Lei D; Pan X
Cancer Biother Radiopharm; 2017 Nov; 32(9):327-334. PubMed ID: 29111780
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation.
Selvaraj N; Budka JA; Ferris MW; Jerde TJ; Hollenhorst PC
Mol Cancer; 2014 Mar; 13():61. PubMed ID: 24642271
[TBL] [Abstract][Full Text] [Related]
28. Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP.
Nelson ML; Kang HS; Lee GM; Blaszczak AG; Lau DK; McIntosh LP; Graves BJ
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10026-31. PubMed ID: 20534573
[TBL] [Abstract][Full Text] [Related]
29. Functional Toll-like Receptor 4 Overexpression in Papillary Thyroid Cancer by MAPK/ERK-Induced ETS1 Transcriptional Activity.
Peyret V; Nazar M; Martín M; Quintar AA; Fernandez EA; Geysels RC; Fuziwara CS; Montesinos MM; Maldonado CA; Santisteban P; Kimura ET; Pellizas CG; Nicola JP; Masini-Repiso AM
Mol Cancer Res; 2018 May; 16(5):833-845. PubMed ID: 29523762
[TBL] [Abstract][Full Text] [Related]
30. Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells.
Selvaraj N; Kedage V; Hollenhorst PC
Cell Commun Signal; 2015 Feb; 13():12. PubMed ID: 25885538
[TBL] [Abstract][Full Text] [Related]
31. EGF suppresses the expression of miR-124a in pancreatic β cell lines via ETS2 activation through the MEK and PI3K signaling pathways.
Yang L; Zhu Y; Kong D; Gong J; Yu W; Liang Y; Nie Y; Teng CB
Int J Biol Sci; 2019; 15(12):2561-2575. PubMed ID: 31754329
[TBL] [Abstract][Full Text] [Related]
32. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program.
Nakerakanti SS; Kapanadze B; Yamasaki M; Markiewicz M; Trojanowska M
J Biol Chem; 2006 Sep; 281(35):25259-69. PubMed ID: 16829517
[TBL] [Abstract][Full Text] [Related]
33. An Rb1-dependent amplification loop between Ets1 and Zeb1 is evident in thymocyte differentiation and invasive lung adenocarcinoma.
Dean KC; Huang L; Chen Y; Lu X; Liu Y
BMC Mol Biol; 2015 Mar; 16():8. PubMed ID: 25880398
[TBL] [Abstract][Full Text] [Related]
34. Combinatorial roles of protein kinase A, Ets2, and 3',5'-cyclic-adenosine monophosphate response element-binding protein-binding protein/p300 in the transcriptional control of interferon-tau expression in a trophoblast cell line.
Das P; Ezashi T; Gupta R; Roberts RM
Mol Endocrinol; 2008 Feb; 22(2):331-43. PubMed ID: 17975022
[TBL] [Abstract][Full Text] [Related]
35. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
36. ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype.
Smith AM; Findlay VJ; Bandurraga SG; Kistner-Griffin E; Spruill LS; Liu A; Golshayan AR; Turner DP
Carcinogenesis; 2012 Mar; 33(3):572-80. PubMed ID: 22232738
[TBL] [Abstract][Full Text] [Related]
37. EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function.
Phuchareon J; McCormick F; Eisele DW; Tetsu O
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3855-63. PubMed ID: 26150526
[TBL] [Abstract][Full Text] [Related]
38. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation.
Foos G; García-Ramírez JJ; Galang CK; Hauser CA
J Biol Chem; 1998 Jul; 273(30):18871-80. PubMed ID: 9668063
[TBL] [Abstract][Full Text] [Related]
39. Ets2 transcription factor, telomerase activity and breast cancer.
Dwyer JM; Liu JP
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):83-7. PubMed ID: 19566835
[TBL] [Abstract][Full Text] [Related]
40. Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites.
Vaughan CA; Deb SP; Deb S; Windle B
Oncotarget; 2014 Jan; 5(2):417-27. PubMed ID: 24481480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]